Formulation and evaluation of a mucoadhesive buccal tablet of mefenamic acid

Abstract

Buccal route of administration has many advantages such as improving patient compliance, bypassing the GIT and hepatic first pass effect. The objectives are to formulate mucoadhesive buccal tablet using Mefenamic acid and compatible excipients, and to evaluate the product using quality control tests and in vitro tests. The ingredients were subjected to Differential Scanning Calorimetry and Fourier Transform Infrared Spectroscopy studies for compatibility test and the results showed no interaction. Two batches of mefenamic buccal tablet were prepared. The tablet thickness and diameter are 3.75 mm and 12 mm respectively. All tablets are within the specification of +/-5%. The in-house tablet hardness is 6.8-15kg and percent friabilation is not more than 0.8%. The disintegration test showed that all tablets disintegrated within 4 hours. The content uniformity showed that tablets are within the range of 85%-115%. The tablet weight is within the 5% range. The percent swelling is 53.83% to 58.86% and moisture absorption is 14.79% to 15.56%. The surface pH of the tablet is close to the salivary pH, which means that it would not irritate the buccal mucosa. The buccal tablet has a mucoadhesiveness of 0.196 to 0.200. There was no change in pH and size after subjecting it to stability studies in human saliva. Drug release studies showed 80.7% to 83.4% after 3 hours. Even after 3 months of subjecting the tablets to 40 ºC and 75% RH, results are within acceptable range. The results show the potential of the formulation as a mucoadhesive buccal tablet.

Superporous acrylic acid and HPMC hydrogels of mefenamic acid: Formulation, characterization and optimization by central composite design

“…The same peaks also appeared at the corresponding melting points in the mixture of polymer and drug (MF@HPMC) as well as in the formulation (SPH) indicating no interaction between the polymer and the drug. A slight shifting and mild diffusion of the corresponding melting peaks of the polymer and drug in their physical mixture as well as in SPH formulation towards the higher temperature indicated that the polymer and drug had retained their pure crystalline form and processing conditions have not harmfully impacted the drug in final SPH ( Li and Castillo, 2020 ; Anwar et al, 2021 ; Zahra et al, 2021 ).…”

Formulation Development and Evaluation of Mucoadhesive Buccal Tablets of Acebutolol Hydrochloride

“…Hardness [23] The tablets were evaluated for their hardness using Pfizer hardness tester. Hardness of tablet is expressed in kg/cm 2 .…”